Obesity Clinical Trial
— ALMSOfficial title:
Activity Level Monitoring Study
Verified date | April 2024 |
Source | Ohio State University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to 1) evaluate the relationship of physical activity to quality of life and psychological functioning among adults with severe obesity (BMI>40) and 2) evaluate the effects of activity monitoring on changes in physical activity during a 6-week intervention interval.
Status | Active, not recruiting |
Enrollment | 38 |
Est. completion date | April 29, 2025 |
Est. primary completion date | April 29, 2025 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - 18 years of age or older - BMI greater than or equal to 40 - Sit or lie down greater than or equal to 9 hours per day Exclusion Criteria: - Participating in regular exercise (any planned exercise) - Participating in a formal weight loss or exercise program - Planning to join a formal weight loss or exercise program in the next 2 months - Cannot stand up without assistance - Currently pregnant - Planning to get pregnant in the next 2 months - Given birth in past 9 months - Currently breast feeding - Weigh over 400 lbs - Highest level of education is below 8th grade - PHQ-9 score less than 15 - Visual impairment that impairs ability to read - Any condition(s) that would make it challenging to follow instructions/directions - Cognitive disorder (e.g., dementia) |
Country | Name | City | State |
---|---|---|---|
United States | The Ohio State University | Columbus | Ohio |
Lead Sponsor | Collaborator |
---|---|
Ohio State University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Sedentary time | Participants will wear activity monitors for the duration of the study. Sedentary time is operationalized as any recorded waking time spent sitting or lying down. | Change from baseline to 6 weeks | |
Primary | Sit to stand transitions | Participants will wear activity monitors for the duration of the study. The monitors will keep track of every time a participant goes from sitting to standing and vice versa. | Change from baseline to 6 weeks | |
Primary | Self-report physical activity | Participants will complete the Modified International Physical Activity Questionnaire - Short Form | Change from baseline to 6 weeks | |
Primary | Physical function | Participants will complete a 60-foot walk test and 30-second chair stand test. | Change from baseline to 6 weeks | |
Primary | Health Related Quality of life | Participants will complete the Medical Outcomes Survey, Short Form-36 | Change from baseline to 6 weeks | |
Secondary | Perceived stress | Participants will complete the Perceived Stress Scale | Change from baseline to 6 weeks | |
Secondary | Psychological distress | Participants will complete the Hospital and Anxiety Scale | Change from baseline to 6 weeks | |
Secondary | Insomnia | Participants will complete the Insomnia Severity Index | Change from baseline to 6 weeks | |
Secondary | Sleep quality | Participants will complete the Pittsburgh Sleep Quality Index | Change from baseline to 6 weeks | |
Secondary | Pain perception measure 1 | Participants will complete the McGill Pain Questionnaire | Change from baseline to 6 weeks | |
Secondary | Pain perception measure 2 | Participants will complete the Visual Analog Scale for Pain | Change from baseline to 6 weeks | |
Secondary | Weight Stigma measure 1 | Participants will complete the Stigma Situations Inventory | Change from baseline to 6 weeks | |
Secondary | Weight Stigma measure 2 | Participants will complete the Weight Bias Internalization Scale | Change from baseline to 6 weeks | |
Secondary | Weight Stigma measure 3 | Participants will complete the Body Appreciation Scale | Change from baseline to 6 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |